Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PIP/USA Touts Benefits Of Prefilled Saline Implants For Breast Augmentation

This article was originally published in The Gray Sheet

Executive Summary

Poly Implants Prostheses' PIP saline prefilled breast implants reduce the potential for leaks or ruptures because the saline entry point is patched prior to sale, and the device is sealed in a double-walled hard-silicone shell, the firm maintains.

You may also be interested in...



PIP Saline Implant Deemed "Not Approvable" Due To Paucity Of Data

Poly Implants Prostheses' premarket approval application for a prefilled saline breast implant included clinical data on only 6.4% of the number of patients deemed necessary by FDA for approval, the agency's General and Plastic Surgery Devices panel determined March 2.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011445

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel